In addition, we also investigated CCT2 protein expression in the HPA cohort, which was expressed at varying degrees in all but glioma, pancreatic, renal, and prostate cancers (Figure 1B), a representative immunohistochemical map of which is shown in Figure 1C. This evidence concerns the gene CCT2 and prostate carcinoma.